ISRN Hematology · 2012 · 22 citations · 53 references
MedicineHematologyPathologyHematopathologyHemostasisStem Cell TransplantationCoagulation DisordersHemostatic DisordersThromboembolic DiseaseThrombosisThrombotic DisordersVascular PathologyCongenital ThrombocytopeniaMicroangiopathic Hemolytic AnemiaThrombosis After Vascular InjuryThrombosis In Hemolytic DisordersThrombosis MechanismsThrombosis Pathophysiology
Thrombotic microangiopathy results from thrombotic occlusion of the microvasculature leading to fragmentation of red blood cells, profound thrombocytopenia, and a microangiopathic hemolytic anemia with elevation of lactate dehydrogenase and negative direct Coomb's test. This constellation of clinical and laboratory findings is not due to one disease entity; rather, it represents a variety of underlying diagnoses. Among the major disease entities are TTP/HUS, which can be congenital or acquired, bacterial infections, medications, vascular or endothelial pathology like Kasabach-Merritt phenomenon, and stem cell transplantation. In this paper, we offer a review of some of the major causes of thrombotic microangiopathy.
53
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga, Sara K. Vesely, Deirdra R. Terrell et al. · Blood · 2009 · 570 citations · Full text
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
O Enjolras, Michel Wassef, E. Mazoyer et al. · The Journal of Pediatrics · 1997 · 499 citations
Medicine, Pathology, Pediatrics +8
Thrombotic Thrombocytopenic Purpura
James N. George · New England Journal of Medicine · 2006 · 480 citations